392 related articles for article (PubMed ID: 3574734)
1. [Therapy of non-metastatic Ewing's sarcoma (pelvis excluded). Results obtained in 48 cases combining local therapy (radiation and/or surgical) and adjuvant chemotherapy with vincristine, adriamycin, dactinomycin and cyclophosphamide].
Sudanese A; Avella M; Toni A; Boriani S; Baldini N; Monesi M; Battistini A; Mancini A; Campanacci M
Minerva Med; 1987 Apr; 78(7):473-82. PubMed ID: 3574734
[TBL] [Abstract][Full Text] [Related]
2. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
Bacci G; Picci P; Ruggieri P; Ferrari S; Mercuri M; Fabbri N; Rosito P; Barbieri E; Ferraro A; Casadei R
J Chemother; 1993 Aug; 5(4):247-57. PubMed ID: 8229153
[TBL] [Abstract][Full Text] [Related]
3. Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy.
Bacci G; Toni A; Avella M; Manfrini M; Sudanese A; Ciaroni D; Boriani S; Emiliani E; Campanacci M
Cancer; 1989 Apr; 63(8):1477-86. PubMed ID: 2924256
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.
Ferrari S; Mercuri M; Rosito P; Mancini A; Barbieri E; Longhi A; Rimondini S; Cesari M; Ruggieri P; Di Liddo M; Bacci G
J Chemother; 1998 Dec; 10(6):484-91. PubMed ID: 9876058
[TBL] [Abstract][Full Text] [Related]
5. Non-metastatic Ewing's sarcoma: results in 98 patients treated with neoadjuvant chemotherapy.
Bacci G; Ferrari S; Avella M; Barbieri E; Picci P; Casadei R; Rosito P; Neri S; Capanna R; Battistini A
Ital J Orthop Traumatol; 1991 Dec; 17(4):449-65. PubMed ID: 1816151
[TBL] [Abstract][Full Text] [Related]
6. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
Tural D; Molinas Mandel N; Dervisoglu S; Oner Dincbas F; Koca S; Colpan Oksuz D; Kantarci F; Turna H; Selcukbiricik F; Hiz M
Jpn J Clin Oncol; 2012 May; 42(5):420-6. PubMed ID: 22416252
[TBL] [Abstract][Full Text] [Related]
7. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829
[TBL] [Abstract][Full Text] [Related]
8. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial.
Dunst J; Jürgens H; Sauer R; Pape H; Paulussen M; Winkelmann W; Rübe C
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):919-30. PubMed ID: 7607966
[TBL] [Abstract][Full Text] [Related]
9. [Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
Bacci G; Ferrari S; Rosito P; Barbieri E; Mercuri M; Brach del Prever A; Iantorno D; Forni C; Campanacci M
Minerva Pediatr; 1995 Nov; 47(11):457-69. PubMed ID: 8684341
[TBL] [Abstract][Full Text] [Related]
10. Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV.
Nilbert M; Saeter G; Elomaa I; Monge OR; Wiebe T; Alvegård TA
Acta Oncol; 1998; 37(4):375-8. PubMed ID: 9743460
[TBL] [Abstract][Full Text] [Related]
11. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
Bacci G; Picci P; Ferrari S; Mercuri M; Brach del Prever A; Rosito P; Barbieri E; Tienghi A; Forni C
Cancer; 1998 Mar; 82(6):1174-83. PubMed ID: 9506366
[TBL] [Abstract][Full Text] [Related]
13. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II.
Burgert EO; Nesbit ME; Garnsey LA; Gehan EA; Herrmann J; Vietti TJ; Cangir A; Tefft M; Evans R; Thomas P
J Clin Oncol; 1990 Sep; 8(9):1514-24. PubMed ID: 2099751
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81.
Sauer R; Jürgens H; Burgers JM; Dunst J; Hawlicek R; Michaelis J
Radiother Oncol; 1987 Oct; 10(2):101-10. PubMed ID: 3423301
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli.
Bacci G; Ferrari S; Bertoni F; Donati D; Bacchini P; Longhi A; Brach Del Prever A; Forni C; Rimondini S
J Clin Oncol; 2000 Feb; 18(4):885-92. PubMed ID: 10673532
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy in Ewing's sarcoma and PNET of the chest wall: results of the trials CESS 81, CESS 86 and EICESS 92.
Schuck A; Hofmann J; Rübe C; Hillmann A; Ahrens S; Paulussen M; Jürgens H; Dunst J; Willich N
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1001-6. PubMed ID: 9869222
[TBL] [Abstract][Full Text] [Related]
17. [The type of local treatment conditions the prognosis in patients with nonmetastatic Ewing's sarcoma of the extremities treated with adjuvant chemotherapy].
Bacci G; Ferrari S; Rosito P; Barbieri E; Mercuri M; Iantorno D; Brach Del Prever A; Ruggieri P; Forni C
Minerva Chir; 1997 Apr; 52(4):415-26. PubMed ID: 9265127
[TBL] [Abstract][Full Text] [Related]
18. Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones.
Evans R; Nesbit M; Askin F; Burgert O; Cangir A; Foulkes M; Gehan E; Gilula L; Kissane J; Makley J
Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):129-36. PubMed ID: 3881374
[TBL] [Abstract][Full Text] [Related]
19. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.
Nesbit ME; Gehan EA; Burgert EO; Vietti TJ; Cangir A; Tefft M; Evans R; Thomas P; Askin FB; Kissane JM
J Clin Oncol; 1990 Oct; 8(10):1664-74. PubMed ID: 2213103
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.
Bacci G; Ferrari S; Bertoni F; Rimondini S; Longhi A; Bacchini P; Forni C; Manfrini M; Donati D; Picci P
J Clin Oncol; 2000 Jan; 18(1):4-11. PubMed ID: 10623687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
